OBIO · Orchestra BioMed Holdings, Inc.
Market Cap
$311.64M
Shares
60.11M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-06-23 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-23 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-02-13 | 2026-02-12 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-28 | 2025-10-24 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-04 | 2025-07-31 | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-06-24 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | 2025-06-24 | |
| 8-K | 2025-04-29 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-25 | 2025-02-19 | |
| 8-K | 2025-02-05 | 2025-01-30 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-07-30 | 2024-07-29 | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-06-11 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-30 | 2024-06-20 | |
| 8-K | 2024-03-29 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-07 | 2024-03-06 | |
| 8-K | 2023-11-28 | 2023-11-21 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-10 | — | |
| 8-K | 2023-09-19 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K/A | 2023-07-13 | 2023-07-12 | |
| 8-K | 2023-07-12 | — | |
| 8-K | 2023-06-08 | 2023-06-05 | |
| 8-K | 2023-06-08 | — | |
| 10-Q | 2023-05-12 | 2023-03-31 | |
| 8-K/A | 2023-03-24 | 2023-01-25 | |
| 8-K | 2023-03-13 | — | |
| 8-K | 2023-01-31 | 2023-01-25 | |
| 10-K | 2023-01-25 | 2022-12-31 | |
| 8-K | 2023-01-25 | 2023-01-24 | |
| 8-K | 2023-01-24 | 2023-01-19 |
Showing 1–50 of 73 filings
Key facts
CIK
1814114
CUSIP
68572M106
13F (30d)
64 filings
64 filers
Visit website
Investor relations